Cryoport, Inc., a leading provider in the biopharmaceutical supply chain, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 2012, the company has established itself as a pivotal player in the temperature-controlled logistics sector, particularly for the life sciences industry. Specialising in cryogenic logistics, Cryoport offers innovative solutions for the transportation of biological materials, including cell and gene therapies. Their unique Cryoport Express® system ensures the integrity and viability of sensitive shipments, setting them apart in a competitive market. With a commitment to quality and compliance, Cryoport has achieved significant milestones, including partnerships with major pharmaceutical companies and a robust network of global facilities. This positions Cryoport as a trusted leader in the critical field of biopharmaceutical logistics.
How does Cryoport's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cryoport's score of 37 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Cryoport, headquartered in the US, reported total carbon emissions of approximately 8,000,000 kg CO2e. This figure includes 1,605,000 kg CO2e from Scope 1 emissions, which encompass mobile combustion (1,023,000 kg CO2e), fugitive emissions (153,000 kg CO2e), and stationary combustion (429,000 kg CO2e). Scope 2 emissions accounted for about 6,672,000 kg CO2e, while Scope 3 emissions were approximately 211,000 kg CO2e, primarily from waste generated in operations. Comparatively, in 2022, Cryoport's total emissions were around 8,000,000 kg CO2e, with Scope 1 emissions at 1,352,000 kg CO2e, Scope 2 emissions at 6,231,000 kg CO2e, and Scope 3 emissions reaching approximately 10,000,000 kg CO2e, which included significant contributions from downstream transportation and distribution. Cryoport has not set specific reduction targets or initiatives as part of its climate commitments, nor does it participate in the Science Based Targets initiative (SBTi). The company has disclosed emissions data across all three scopes, demonstrating transparency in its environmental impact reporting.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | |
---|---|---|---|
Scope 1 | 2,613,000 | 0,000,000 | 0,000,000 |
Scope 2 | 6,988,000 | 0,000,000 | 0,000,000 |
Scope 3 | 142,000 | 00,000,000 | 000,000 |
Cryoport's Scope 3 emissions, which decreased by 98% last year and increased by approximately 49% since 2021, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 2% of total emissions under the GHG Protocol, with "Waste Generated in Operations" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cryoport has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.